Corticosteroid Use in Patients with Glioblastoma at First or Second Relapse Treated with Bevacizumab in the BRAIN Study

BACKGROUND. Vascular endothelial growth factor inhibitors have corticosteroid-sparing effects in patients with high-grade gliomas. We assessed corticosteroid use in patients with recurrent glioblastoma treated with bevacizumab (BEV) in the BRAIN study (J Clin Oncol 2009;27:4733–4740). METHODS. BRAIN...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Vredenburgh, James J., Cloughesy, Timothy, Samant, Meghna, Prados, Michael, Wen, Patrick Y., Mikkelsen, Tom, Schiff, David, Abrey, Lauren E., Yung, W.K. Alfred, Paleologos, Nina, Nicholas, Martin K., Jensen, Randy, Das, Asha, Friedman, Henry S.
Format: Artigo
Langue:Inglês
Publié: AlphaMed Press 2010
Sujets:
Neuro-Oncology
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3227925/
https://ncbi.nlm.nih.gov/pubmed/21147867
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2010-0105
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires